# Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder

> **NCT04179734** · PHASE4 · COMPLETED · sponsor: **Imperial College Healthcare NHS Trust** · enrollment: 40 (actual)

## Conditions studied

- Hypoactive Sexual Desire Disorder

## Interventions

- **DRUG:** Bremelanotide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04179734
- **Lead sponsor:** Imperial College Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-07
- **Primary completion:** 2020-10-06
- **Final completion:** 2020-10-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04179734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04179734, "Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04179734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*